Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | Common Stock | +Options Exercise | $170,346 | +787 | +46.35% | $216.45 | 2,485 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | -Tax liability | -$62,338 | -288 | -11.59% | $216.45 | 2,197 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | +Options Exercise | $84,199 | +389 | +17.71% | $216.45 | 2,586 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | -Tax liability | -$24,892 | -115 | -4.45% | $216.45 | 2,471 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | +Options Exercise | $92,208 | +426 | +17.24% | $216.45 | 2,897 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | -Tax liability | -$27,273 | -126 | -4.35% | $216.45 | 2,771 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | +Options Exercise | $76,840 | +355 | +12.81% | $216.45 | 3,126 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | -Tax liability | -$22,727 | -105 | -3.36% | $216.45 | 3,021 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | +Options Exercise | $477,272 | +2,205 | +72.99% | $216.45 | 5,226 | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | -Tax liability | -$140,476 | -649 | -12.42% | $216.45 | 4,577 | Mar 1, 2024 | Direct | |
holding | AVY | Common Stock (Savings Plan) | 1,424 | Mar 1, 2024 | Savings Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | 2024 MSU Award | +Grant/Award | $0 | +1,321 | $0.00 | 1,321 | Mar 1, 2024 | Common Stock | 1,321 | $0.00 | Direct | F1 | |
transaction | AVY | 2024 PU Award | +Grant/Award | $0 | +1,507 | $0.00 | 1,507 | Mar 1, 2024 | Common Stock | 1,507 | $0.00 | Direct | F2 | |
transaction | AVY | 2020 MSU Award | -Options Exercise | $0 | -787 | -100% | $0.00 | 0 | Mar 1, 2024 | Common Stock | 787 | $0.00 | Direct | F3 |
transaction | AVY | 2021 MSU Award | -Options Exercise | $0 | -389 | -58.32% | $0.00 | 278 | Mar 1, 2024 | Common Stock | 389 | $0.00 | Direct | F4 |
transaction | AVY | 2022 MSU Award | -Options Exercise | $0 | -426 | -32.62% | $0.00 | 880 | Mar 1, 2024 | Common Stock | 426 | $0.00 | Direct | F5 |
transaction | AVY | 2023 MSU Award | -Options Exercise | $0 | -355 | -24.91% | $0.00 | 1,070 | Mar 1, 2024 | Common Stock | 355 | $0.00 | Direct | F6 |
transaction | AVY | 2021 PU Award | -Options Exercise | $0 | -2,205 | -100% | $0.00 | 0 | Mar 1, 2024 | Common Stock | 2,205 | $0.00 | Direct | F7 |
Id | Content |
---|---|
F1 | Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
F2 | Performance units (PUs) vest, at the end of fiscal year 2026, provided certain performance objectives are met as determined by the Compensation Committee in February 2027. Each PU represents a contingent right to receive one share of common stock. |
F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2020 at 180% of target based on our absolute total stockholder return in excess of 10% during the 2020-2023 performance period, plus dividend equivalents accrued during the period. |
F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2021 at 134% of target based on our absolute total stockholder return in excess of 10% during the 2021-2023 performance period, plus dividend equivalents accrued during the period. |
F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2022 at 94% of target based on our absolute total stockholder return during the 2022-2023 performance period, plus dividend equivalents accrued during the period. |
F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2023 at 98% of target based on our absolute total stockholder return during the 2023 performance period, plus dividend equivalents accrued during the period. |
F7 | Shares reflect the vesting of PUs granted in March 2021 at 183% of target, based 50% on our cumulative economic value added and 50% on our relative total stockholder return. |